Premium
Nupafant, a PAF‐antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?
Author(s) -
Baker K E,
Wood L M,
Whittaker M,
Curtis M J
Publication year - 2006
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0706958
Subject(s) - qt interval , ventricular fibrillation , antagonist , cardiology , medicine , ischemia , anesthesia , receptor
British Journal of Pharmacology (2006) 149 , 966. doi:10.1038/sj.bjp.0706958
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom